Create a free Clinical OMICs account to comment on articles, save favorites, create a profile, and more. By opting in below, you will also receive a free subscription to the digital version of Clinical OMICs Magazine and our eNewsletter.
Already have a Clinical OMICs account? Log In
Your first & last name
This field can be seen by: Everyone Change
This field can be seen by: Only Me
![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
